Information for Tirzepatide
Page information·measured at build time
Technical and provenance information about Tirzepatide. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Tirzepatide |
|---|---|
| Default sort key | Tirzepatide |
| Namespace | Article (main) |
| Page kind | Compound |
| Page length (source, bytes) | 8,037 |
| Rendered word count | 944 |
| Internal wiki links on the page | 31 |
| Defined citations | 5 |
| Top-level sections | 4 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — compound |
| Maintenance banners | medical |
| Indexing by robots | Allowed |
Edit history
| Page creator | MolarMassMaeve |
|---|---|
| Date of page creation | 13 June 2024 |
| Latest editor | LiraLotte |
| Date of latest edit | 16 July 2026 |
| Total number of edits | 37 |
| Total number of distinct authors | 28 |
| Minor edits | 15 |
| Automated (bot) edits | 6 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 8 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| MolarMassMaeve | 3 | 8.1% | GLP-1 receptor agonists and related compounds |
| CategoryBot | 2 | 5.4% | categorisation and navigation |
| IcodecIndra | 2 | 5.4% | GLP-1 receptor agonists and related compounds |
| Chromatokid | 2 | 5.4% | analytical chemistry and chromatography |
| OralSemaOswin | 2 | 5.4% | GLP-1 receptor agonists and related compounds |
| OrforglipronOona | 2 | 5.4% | GLP-1 receptor agonists and related compounds |
| TimelineTiernan | 2 | 5.4% | GLP-1 receptor agonists and related compounds |
| ArchiveBot | 2 | 5.4% | policy, notability and deletion |
| DulaglutideDug | 1 | 2.7% | GLP-1 receptor agonists and related compounds |
| AxisLabelAgda | 1 | 2.7% | diagrams and figures |
| GlossaryGaspar | 1 | 2.7% | copy-editing and the manual of style |
| EndotoxinEd | 1 | 2.7% | third-party testing and certificates of analysis |
Category membership
- Category:Dual and triple agonists — 5 member pages
- Category:Peptide drugs — 17 member pages
- Category:Pharmacokinetics — 12 member pages
- Category:Articles describing unapproved compounds — 21 member pages
- Category:Articles describing unapproved compounds (maintenance)